Lysosome‐Lipid Droplet Interactions in Fatty Acid Metabolism

脂肪酸代谢中的溶酶体与脂滴相互作用

基本信息

  • 批准号:
    10501725
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

The interactions between lysosomes and lipid droplets represent the processes of mobilization of lipids and energy required for cell metabolism and lipid homeostasis. Lipophagy, for lipid degradation, is a known type of lysosome-lipid droplet interaction. Our preliminary studies and results from others suggest there is a second type of lysosome-lipid droplet interaction, which mediates lipid transport from lysosomes to lipid droplets for lipid synthesis and storage. This process is probably mediated by the organelle membrane contact sites (MCS), which are recently defined as tethered organelles, organized by protein-protein and protein-lipid interactions. MCS provide vectorial transport of lipids between heterologous organelles and are increasingly appreciated for their role in lipid homeostasis. Our group will study lysosome-lipid droplet interactions with a focus of lysosome-lipid droplet MCS in the context of fatty acid metabolism. Regulation of free fatty acids within the cell is critical for normal cell functions, as excess cytosolic free fatty acids cause toxic effects to cells and tissues (named lipotoxicity) and thus have been recognized as a causative factor in many metabolic disorders, including non-alcoholic fatty liver disease (NAFLD). One source of cytosolic free fatty acids is the lysosome, which releases free fatty acids after digesting endocytosed extracellular lipids and autophagic intracellular membranes and lipids. Increasing the transport and storage of free fatty acids into lipid droplets protects cells, including liver cells, from lipotoxicity. Therefore, lysosome-lipid droplet MCS may play an important role in prevention of lysosomal free fatty acid-induced lipotoxicity. However, it is not clear whether MCS exist between lysosomes and lipid droplets and whether lysosome-lipid droplet MCS transport free fatty acids. Moreover, it is not known whether lysosome-lipid droplet MCS play a role in preventing lysosome- triggered lipotoxicity and regulating fatty acid metabolism. Our recent studies support the existence of lysosome-lipid droplet MCS in human liver cells, and we identified the protein-protein interactions at lysosome-lipid droplet MCS through a genetic screening in yeast. In the next five years, we will define the principal components and function of lysosome-lipid droplet MCS, and test if promoting MCS formation will prevent or reduce lipotoxicity and thus NAFLD progression in a mouse model. By investigating the features, mechanisms, and physiological functions of lysosome-lipid droplet MCS, our work will reveal a previously undefined interaction between lysosomes and lipid droplets and uncover a novel mechanism of free fatty acid transport. This mechanism will deepen the understandings to fatty acid metabolism, lipotoxicity, and the pathology of NAFLD.
溶酶体和脂滴之间的相互作用代表了脂质的动员过程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Pu其他文献

Jing Pu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Pu', 18)}}的其他基金

Lysosome‐Lipid Droplet Interactions in Fatty Acid Metabolism
脂肪酸代谢中的溶酶体与脂滴相互作用
  • 批准号:
    10656506
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Lysosome Dynamics-Regulated Lipid Metabolism in Pancreatic Cancer
溶酶体动力学调节胰腺癌的脂质代谢
  • 批准号:
    10249121
  • 财政年份:
    2017
  • 资助金额:
    $ 38.13万
  • 项目类别:
Lysosome Dynamics-Regulated Lipid Metabolism in Pancreatic Cancer
溶酶体动力学调节胰腺癌的脂质代谢
  • 批准号:
    10097972
  • 财政年份:
    2017
  • 资助金额:
    $ 38.13万
  • 项目类别:
Lysosome Dynamics-Regulated Lipid Metabolism in Pancreatic Cancer
溶酶体动力学调节胰腺癌的脂质代谢
  • 批准号:
    10091809
  • 财政年份:
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似国自然基金

分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 批准年份:
    2020
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 批准年份:
    2019
  • 资助金额:
    20.5 万元
  • 项目类别:
    青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
  • 批准号:
    81402419
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
  • 批准号:
    81271563
  • 批准年份:
    2012
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
  • 批准号:
    31272541
  • 批准年份:
    2012
  • 资助金额:
    82.0 万元
  • 项目类别:
    面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
  • 批准号:
    31271248
  • 批准年份:
    2012
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
  • 批准号:
    81160050
  • 批准年份:
    2011
  • 资助金额:
    49.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Investigating bioengineering approaches to produce immuno-modulatory mesenchymal stromal cells and their extracellular vesicle
研究生产免疫调节间充质基质细胞及其细胞外囊泡的生物工程方法
  • 批准号:
    2608627
  • 财政年份:
    2025
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Studentship
根での内外的傷害の初動対処となる新規の傷害防衛戦略"Cellsロック"
“细胞锁”是一种新的损伤防御策略,从根源上对内伤和外伤进行初步反应。
  • 批准号:
    24KJ2131
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells
SBIR 第一阶段:成熟人类脂肪细胞药物开发的工业规模技术
  • 批准号:
    2322443
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Standard Grant
CAREER: Understanding how hierarchical organization of growth plate stem cells controls skeletal growth
职业:了解生长板干细胞的分层组织如何控制骨骼生长
  • 批准号:
    2339761
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Continuing Grant
Recyclable, smart and highly efficient wire-shaped solar cells waved portable/wearable electronics
可回收、智能、高效的线形太阳能电池挥舞着便携式/可穿戴电子产品
  • 批准号:
    24K15389
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Next Generation Fluorescent Tools for Measuring Autophagy Dynamics in Cells
用于测量细胞自噬动态的下一代荧光工具
  • 批准号:
    DP240100465
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Discovery Projects
Dissecting the heterogeniety of human tissue-resident memory T cells
剖析人体组织驻留记忆 T 细胞的异质性
  • 批准号:
    DE240101101
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Discovery Early Career Researcher Award
Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
  • 批准号:
    24K19213
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
MARVEL-ous Extracellular vesicles carry RXLR effectors into host plant cells
MARVEL-ous 细胞外囊泡携带 RXLR 效应子进入宿主植物细胞
  • 批准号:
    BB/Y002067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Research Grant
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
  • 批准号:
    MR/Y003683/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了